Zhang, P., Zhang, P., Xie, D., Xie, D., Li, Q., & Li, Q. (2021). Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A.
芝加哥风格引文Zhang, Peng-Fei, Peng-Fei Zhang, Dan Xie, Dan Xie, Qiu Li, 与 Qiu Li. Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A, 2021.
MLA引文Zhang, Peng-Fei, et al. Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A, 2021.
警告：这些引文格式不一定是100％准确.